Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation-Reference-Cited by-同舟云学术

Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation

Published:2004-12 Issue:24 Volume:14 Page:6095-6099
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Jaramillo Carlos,de Diego J. Eugenio,Hamdouchi Chafiq,Collins Elizabeth,Keyser Heather,Sánchez-Martı́nez Concha,del Prado Miriam,Norman Bryan,Brooks Harold B.,Watkins Scott A.,Spencer Charles D.,Dempsey Jack Alan,Anderson Bryan D.,Campbell Robert M.,Leggett Tellie,Patel Bharvin,Schultz Richard M.,Espinosa Juan,Vieth Michal,Zhang Faming,Timm David E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. Cancer Cell Cycles

2. Oncoprotein Networks

3. To cycle or not to cycle: a critical decision in cancer

4. The Molecular Basis of Cell Cycle and Growth Control;Stein,1998

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of New Imidazo[1,2‐a]pyridine Triazole Hybrid Molecules as Potential Apoptotic Antitumor Agents;ChemistrySelect;2024-02-22

2. Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review;Bioorganic Chemistry;2023-11

3. Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM;Journal of Ethnopharmacology;2023-03

4. Fused Pyridine Derivatives: Synthesis and Biological Activities;Exploring Chemistry with Pyridine Derivatives;2023-01-04

5. Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action;RSC Medicinal Chemistry;2023